menu close
synthekine.com/

Synthekine Stock

Company Profile:

Synthekine is an engineered cytokine therapeutics company developing disease-optimized treatments. The company uses immunological insights to guide targeted protein engineering to generate transformative medicines for cancer and autoimmune disorders.

Sign up for SecondMarket™ to view the market and buy or sell Synthekine Stock
Buy + Sell
Leverage Your Equity to Help Achieve More.

Synthekine Management Team

  • Director

    Mardi Dier

  • Chief Medical Officer

    Naiyer Rizvi

  • Director

    Pablo J. Cagnoni

  • Director

    Srinivas Akkaraju

  • Director

    Larry Lasky

  • CEO

    Debanjan Ray

  • Director

    Julie Grant

  • Chief Development Officer

    Martin Oft

  • Founder

    Christopher Garcia

  • Director

    Nils Lonberg

Synthekine Major Investors

  • Deerfield Management Company

  • Lilly Asia Ventures

  • Omega Funds

  • Samsara BioCapital

  • TCG X

  • Rock Springs Capital

  • Emerson Collective LLC

  • Canaan Partners

  • RA Capital Management LLC

  • Column Group

Learn More About Synthekine Stock

Buy Synthekine Stock
01

Synthekine stock does not trade on public stock exchanges. Synthekine stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Synthekine stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Synthekine Stock
02

Synthekine Stock does not trade on public stock exchanges. In order to sell Synthekine shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Synthekine Stock Price
03

Synthekine does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Synthekine share price and other valuable private market data.

Read more about secondary market private company stock prices:

Synthekine Stock Ticker Symbol
04

There is no ticker symbol for Synthekine stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Synthekine Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Synthekine stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Synthekine Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Synthekine stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Synthekine Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Synthekine IPO
08

Synthekine is a private company and has not had an IPO. There is currently no Synthekine IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Synthekine IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket™ to view the market and buy or sell Synthekine Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

Uses revolutionary technology to discover novel treatments for life-threatening diseases.

Indigoag-Logo

Indigo Agriculture

Improves grower profitability, environmental sustainability, and consumer health through the use of natural microbiology and digital technologies.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Color-Logo

Color Health

Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

Inariag-Logo

Inari Agriculture

Uses AI-powered predictive design and gene editing to create sustainable, nature-positive seeds for a more efficient food system.

Medable Inc.-Logo

Medable

Global cloud platform for decentralized clinical trials.

Source: Nasdaq Private Market Tape D™